Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction to: Coumaric acid from M. polymorphum extracts reverses the activated state of hepatic stellate cells (GRX) and inhibits their proliferation by decreasing the p53/p21 pathway.
Bastos MS, Saalfeld RM, Costa BP, Antunes KH, Melo D, Donadio MVF, Santarém ER, de Oliveira JR. Bastos MS, et al. Among authors: saalfeld rm. Naunyn Schmiedebergs Arch Pharmacol. 2023 May;396(5):1075. doi: 10.1007/s00210-023-02408-6. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36710279 No abstract available.
Moquiniastrum polymorphum subsp. polymorphum extract inhibits the proliferation of an activated hepatic stellate cell line (GRX) by regulating the p27 pathway to generate cell cycle arrest.
Bastos MS, Saalfeld RM, Costa BP, Garcia MC, Antunes KH, Rodrigues KF, Melo D, Santarém ER, de Oliveira JR. Bastos MS, et al. Among authors: saalfeld rm. J Ethnopharmacol. 2023 Mar 1;303:116056. doi: 10.1016/j.jep.2022.116056. Epub 2022 Dec 16. J Ethnopharmacol. 2023. PMID: 36535332 Free article.
Coumaric acid from M. polymorphum extracts reverses the activated state of hepatic stellate cells (GRX) and inhibits their proliferation by decreasing the p53/p21 pathway.
Bastos MS, Saalfeld RM, Costa BP, Antunes KH, Melo D, Donadio MVF, Santarém ER, de Oliveira JR. Bastos MS, et al. Among authors: saalfeld rm. Naunyn Schmiedebergs Arch Pharmacol. 2023 May;396(5):925-937. doi: 10.1007/s00210-022-02361-w. Epub 2022 Dec 15. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36520165
The Grand SANS FLUORO (SAy No Series to FLUOROsopy) Study: Examining Fluoroscopy Use in More than 1,000 Ablation Procedures.
Percell RL, Pike JL, Olmsted RK, Beideck JE, Nunes HL, Johnson KN, Schaffer M, Vachok LB, Sveen SM, Keim EJ, Mohr-Burt SO, Saalfeld RM, Beran CA, Allison TW, Stock JF. Percell RL, et al. Among authors: saalfeld rm. J Innov Card Rhythm Manag. 2020 Sep 15;11(9):4224-4232. doi: 10.19102/icrm.2020.1100903. eCollection 2020 Sep. J Innov Card Rhythm Manag. 2020. PMID: 32983591 Free PMC article.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.